A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
Eligible age
3–13 yrs
Accepts
All genders
Locations
28 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A randomized trial to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential treatment, first with spectacles alone followed by patching (if needed), for previously untreated amblyopia in children 3 to \<13 years of age.
Sponsor: Jaeb Center for Health Research
You may qualify if…
- ✓ 1. Age 3 to \<13 years at the time of randomization
- ✓ 2. Amblyopia associated with anisometropia, strabismus, or both
- ✓ o Criteria for strabismic amblyopia: At least one of the following must be met:
- ✓ Presence of a heterotropia on examination at distance or near fixation (with or without optical correction)
- ✓ Documented history of strabismus which is no longer present (which in the judgment of the investigator could have caused amblyopia)
- ✓ Criteria for anisometropia: At least one of the following criteria must be met:
- ✓ 1.00 D difference between eyes in spherical equivalent (SE)
- ✓ 1.50 D difference in astigmatism between corresponding meridians in the two eyes
You may not qualify if…
- ✕ 1. Myopia greater than -6.00 D spherical equivalent in either eye.
- ✕ 2. Previous intraocular or refractive surgery.
- ✕ 3. Planned strabismus surgery in the next 56 weeks.
- ✕ 4. Any previous treatment for amblyopia (patching, atropine, Bangerter filter, vision therapy, or binocular treatment).
- ✕ 5. Previous spectacle or contact lens wear for more than 24 hours.
- ✕ 6. Parent and participant willing to forego option of contact lens wear for the duration of the study.
- ✕ 7. Ocular co-morbidity that may reduce VA determined by an ocular examination performed within the past 7 months (Note: nystagmus per se does not exclude the participant if the above VA criteria are met).
- ✕ 8. Severe developmental delay that would interfere with treatment or evaluation (in the opinion of the investigator). Participants with mild speech delay or reading and/or learning disabilities or attention deficit hyperactivity disorder (ADHD) are not excluded.
Where it's recruiting
Birmingham
Glendale · Phoenix · Tucson
Berkeley · Fullerton · Irvine · Loma Linda …
Milford
Fort Lauderdale · Jacksonville · Tampa
Boise
Chicago · Chicago Ridge · Downers Grove · Lisle
Bloomington · Indianapolis
West Des Moines
Baltimore
Boston
Grand Rapids
Source: ClinicalTrials.gov · NCT04378790 · last updated 2026-02-11